SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbstock Regulatory News (IBST)

Share Price Information for Ibstock (IBST)

Share Price is delayed by 15 minutes
Get Live Data
95.00    3.15 (3.43%)
Bid:
95.05
Ask:
95.60
Spread: 0.55 (0.579%)
Market Cap: £375.27m
IBST Live PriceLast checked at - London Stock Exchange

Intraday Ibstock Share Chart

Directorate Change

1 Aug 2019 10:26

RNS Number : 5564H
Ibstock PLC
01 August 2019
 

1 August 2019

 

Ibstock plc

 

Director Change

 

 

Further to the announcement issued on 6 February 2019, Ibstock plc ('Ibstock' or the 'Company') announces that Chris McLeish has today been appointed a director of the Company.

 

Enquiries

Citigate Dewe Rogerson

Kevin Smith

Nick Hayns

+ 44 (0)20 7638 9571

 

 

 Notes to Editors:

Remuneration:

Chris McLeish's remuneration arrangements, which are consistent with the Directors' Remuneration Policy approved by shareholders, will take effect from 1 August 2019, as summarised below:

·;

Base salary - £300,000 p.a.;

·;

Pension - 10% of salary cash allowance;

·;

Annual bonus opportunity - up to 125% of salary; and

·;

Long Term Incentive Plan - 125% of salary for 2019 (normal award for 2019 is 100% of salary for Executive Directors). The increased quantum for 2019 was negotiated as part of Mr McLeish's recruitment from Tate & Lyle plc in lieu of one of the Tate & Lyle share awards which is not otherwise covered under the buy-out arrangements. From 2020 onwards awards of 150% of salary will be made, subject to performance

Chris also held a number of cash and share incentives under various Tate & Lyle plc incentive plans. In line with the approved Directors' Remuneration Policy, replacement awards form part of the recruitment remuneration.

A cash payment of £97,949 will be made to Chris on appointment to compensate the value of his 2018 annual bonus earned which was forfeited on cessation.

In addition, it has been agreed to grant a buy-out award of 60,393 Ibstock plc ordinary shares of 1p each. The award is to compensate, on a fair value basis, the value forgone by Chris McLeish for share awards forfeited on cessation of employment with his previous employer. The fair value of the award has been reduced to take account of the original performance period and the proportion of satisfaction of the performance conditions as at the time of the buy-out. The vesting level will be revisited at the time of vesting to adjust the number of Ibstock shares which vest to reflect the actual vesting of the original Tate & Lyle awards.

Full disclosure of these remuneration arrangements will be provided in the Directors' Remuneration Report to be published in 2020.

Ibstock plc is a leading manufacturer of clay bricks with a diversified range of clay and concrete products, and operations in the United Kingdom and the United States. Its principal products are clay bricks, brick components, concrete roof tiles, concrete substitutes for stone masonry, concrete fencing and general concrete building products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEANPFEASNEEF
Date   Source Headline
22nd May 20269:00 amRNSHolding(s) in Company
21st May 20261:51 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Trading Update
14th May 202611:00 amRNSHolding(s) in Company
13th May 20263:55 pmRNSHolding(s) in Company
13th May 20263:39 pmRNSHolding(s) in Company
1st May 20268:26 amRNSTotal Voting Rights
29th Apr 20264:11 pmRNSHolding(s) in Company
21st Apr 20262:38 pmRNSDirector/PDMR Shareholding
21st Apr 20267:03 amRNSAppointment of Chief Financial Officer
17th Apr 202611:00 amRNSDirector/PDMR Shareholding
10th Apr 20263:00 pmRNSDirector/PDMR Shareholding
1st Apr 20269:04 amRNSTotal Voting Rights
25th Mar 20269:16 amRNSNotice of AGM
24th Mar 20262:17 pmRNSHolding(s) in Company
17th Mar 20264:00 pmRNSDirector/PDMR Shareholding
11th Mar 20263:15 pmRNSHolding(s) in Company
6th Mar 20263:00 pmRNSHolding(s) in Company
5th Mar 20267:01 amRNSAppointment of Non-Executive Director
5th Mar 20267:00 amRNSResults for the year ended 31 December 2025
2nd Mar 202610:02 amRNSTotal Voting Rights
25th Feb 202610:00 amRNSHolding(s) in Company
2nd Feb 20264:21 pmRNSTotal Voting Rights
22nd Jan 20268:55 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
12th Jan 20262:51 pmRNSHolding(s) in Company
2nd Jan 202610:00 amRNSBlock listing Six Monthly Return
11th Dec 20253:00 pmRNSHolding(s) in Company
13th Nov 20252:00 pmRNSRefinancing of £125m revolving credit facility
10th Oct 20257:00 amRNSThird Quarter Trading Update
2nd Oct 202510:00 amRNSDirectorate Change
1st Oct 20258:04 amRNSTotal Voting Rights
26th Sep 20252:30 pmRNSHolding(s) in Company
16th Sep 20252:00 pmRNSDirector/PDMR Shareholding
29th Aug 20253:30 pmRNSHolding(s) in Company
29th Aug 202510:00 amRNSHolding(s) in Company
22nd Aug 202512:21 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSInterim Results
30th Jul 20252:00 pmRNSHolding(s) in Company
18th Jul 202511:00 amRNSHolding(s) in Company
15th Jul 20257:00 amRNSNotice of Results
10th Jul 20259:30 amRNSHolding(s) in Company
4th Jul 20259:30 amRNSHolding(s) in Company
3rd Jul 20253:00 pmRNSBlock listing Interim Review
3rd Jul 202512:00 pmRNSTotal Voting Rights
3rd Jul 20259:30 amRNSHolding(s) in Company
23rd Jun 20258:26 amRNSReport on Payments to Govts
20th Jun 202512:31 pmRNSDirector/PDMR Shareholding
12th Jun 20253:00 pmRNSHolding(s) in Company
12th Jun 20252:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.